A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Institut Bergonié
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Amgen
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
Amgen
Merck Sharp & Dohme LLC
Altor BioScience